News & Updates

Tirzepatide: A winning weight-loss therapy for nondiabetic, obese adults
Tirzepatide: A winning weight-loss therapy for nondiabetic, obese adults
25 Jun 2022 byRoshini Claire Anthony

Non-diabetic overweight or obese adults experienced a greater reduction in weight and cardiometabolic measures with the addition of tirzepatide to their lifestyle interventions, findings of the SURMOUNT-1 trial showed.

Tirzepatide: A winning weight-loss therapy for nondiabetic, obese adults
25 Jun 2022